Michael Resl
Impact in
-
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
- Rheumatology top 5%
- GDF15 and Related Biomarkers
Papers in
-
- Diabetes Treatment and Management 10
- Diabetes Management and Research 7
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 5
- Surgery 10
- Co-authors
- Martin Clodi (38 shared papers)Anton Luger (15 shared papers)Greisa Vila (15 shared papers)Richard Pacher (13 shared papers)Stephanie Neuhold (12 shared papers)Guido Strunk (10 shared papers)Rudolf Prager (11 shared papers)Michaela Riedl (10 shared papers)
In The Last Decade
Michael Resl
52 papers receiving 906 citations
Peers
Comparison fields: 5 of 83
- Cardiology and Cardiovascular Medicine 361
- Rheumatology 210
- Endocrinology, Diabetes and Metabolism 151
- Biological Psychiatry 16
- Nephrology 41
Countries citing papers authored by Michael Resl
This map shows the geographic impact of Michael Resl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Resl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Resl more than expected).
Fields of papers citing papers by Michael Resl
This network shows the impact of papers produced by Michael Resl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Resl. The network helps show where Michael Resl may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Resl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 223 | |
| 2 | 2010 | 154 | |
| 3 | 2008 | 54 | |
| 4 | 2012 | 51 | |
| 5 | 2011 | 40 | |
| 6 | 2009 | 35 | |
| 7 | 2016 | 33 | |
| 8 | 2021 | 28 | |
| 9 | 2016 | 27 | |
| 10 | 2009 | 26 | |
| 11 | 2011 | 26 | |
| 12 | 2021 | 23 | |
| 13 | 2011 | 21 | |
| 14 | 2011 | 17 | |
| 15 | 2016 | 14 | |
| 16 | 2008 | 14 | |
| 17 | 2010 | 13 | |
| 18 | 2019 | 13 | |
| 19 | 2017 | 9 | |
| 20 | 2016 | 7 |
About Michael Resl
Michael Resl is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Cardiology and Cardiovascular Medicine, Epidemiology and Genetics, having authored 55 papers that have together received 923 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (10 papers), Diabetes and associated disorders (7 papers), Diabetes Management and Research (7 papers), Heart Failure Treatment and Management (6 papers), GDF15 and Related Biomarkers (5 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (5 papers), Cardiovascular Function and Risk Factors (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (361 citations), Rheumatology (210 citations), Endocrinology, Diabetes and Metabolism (151 citations), Biological Psychiatry (16 citations) and Nephrology (41 citations). Michael Resl has collaborated with scholars based in Austria, Germany and Australia. Frequent co-authors include Martin Clodi, Anton Luger, Greisa Vila, Richard Pacher, Stephanie Neuhold, Guido Strunk, Rudolf Prager, Michaela Riedl, Christopher Adlbrecht and Martin Hülsmann. Their work appears in journals such as Journal of Applied Physiology, Heart, Clinical Chemistry, Wiener klinische Wochenschrift and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.